Sofosbuvir
Showing 51 - 75 of 431
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- ABT-493/ABT-530
- +2 more
- (no location specified)
Jul 14, 2021
Chronic Hepatitis C Trial in Porto Alegre (Telemedicine, Velpatasvir/Sofosbuvir)
Active, not recruiting
- Chronic Hepatitis C
- Telemedicine
- Velpatasvir/Sofosbuvir
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clínicas de Porto Alegre
Aug 24, 2021
Strategies for Hepatitis C Testing and Treatment in Aboriginal
Recruiting
- Hepatitis C
- +5 more
- Fingerstick GeneXpert HCV RNA quantitative assay
- +2 more
-
Lismore, New South Wales, Australia
- +3 more
Apr 13, 2022
Hepatitis C Trial in Tanta (Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a)
Completed
- Hepatitis C
- Sofosbuvir
- +7 more
-
Tanta, Egypt
- +1 more
Aug 1, 2020
Hepatitis C, Cryoglobulinemia Trial in New York (Harvoni, Epclusa)
Completed
- Hepatitis C
- Cryoglobulinemia
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 23, 2020
SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients
Recruiting
- Hepatitis C
- Epclusa (sofosbuvir and velpatasvir)
-
Guangzhou, Guangdong, ChinaDeparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021
Hepatitis C, HIV Coinfection Trial in Aurora (TDF with a boosted protease inhibitor, TAF with a boosted protease inhibitor, TAF
Completed
- Hepatitis C
- HIV Coinfection
- TDF with a boosted protease inhibitor
- +2 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 21, 2021
COVID-19 Trial in Johannesburg (Standard of care (Paracetamol), Artesunate-amodiaquine, Pyronaridine-artesunate)
Completed
- COVID-19
- Standard of care (Paracetamol)
- +4 more
-
Johannesburg, South AfricaEzintsha, Wits Reproductive Health & HIV Institute University of
Sep 16, 2021
Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment
Recruiting
- Liver Fibroses
- +4 more
- Observation only
-
Ansan, Korea, Republic of
- +25 more
Oct 10, 2021
Hepatitis C, Liver Inflammation, Liver Cirrhoses Trial in Australia (Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet,
Recruiting
- Hepatitis C
- +2 more
- Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
- Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
-
Randwick, New South Wales, Australia
- +6 more
Mar 28, 2022
Hepatitis C, Transplantation Disease Transmission Trial in United States (Sofosbuvir/Velpatasvir,
Completed
- Hepatitis C
- Transplantation Disease Transmission
-
San Francisco, California
- +5 more
Feb 10, 2021
HIV-1-infection, Hepatic Impairment Trial in Smolensk (Elpida®, Dolutegravir, Sofosbuvir)
Completed
- HIV-1-infection
- Hepatic Impairment
- Elpida®
- +3 more
-
Smolensk, Russian FederationRegional State Budgetary Healthcare Institution "Smolensk Region
Jan 10, 2022
Fixed-dose Combination Sofosdac® 400mg/60mg in Chronic Hepatitis
Completed
- Chronic Hepatitis c
- Sofosdac®
-
Boufarik, Blida, Algeria
- +3 more
Nov 16, 2021
Hepatitis C Infection Trial in United States (MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2))
Terminated
- Hepatitis C Infection
- MBL-HCV1
- +2 more
-
Boston, Massachusetts
- +4 more
Feb 4, 2021
Kidney Transplant, Hepatitis C, HCV Trial in Columbus (Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir
Completed
- Kidney Transplant
- +2 more
- Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
- Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]
-
Columbus, OhioBrenda Cuson
Jul 29, 2021
Hepatitis C Trial in Worldwide (SOF/VEL for 6 weeks, SOF/VEL for 12 weeks)
Completed
- Hepatitis C
- SOF/VEL for 6 weeks
- SOF/VEL for 12 weeks
-
Baltimore, Maryland
- +24 more
Nov 22, 2021
Chronic Hepatitis C Trial in Jilin (HEC110114 Tablet, Sofosbuvir Tablet)
Completed
- Chronic Hepatitis C
- HEC110114 Tablet
- Sofosbuvir Tablet
-
Jilin, Changchun, ChinaThe First Hospital of Jilin University
Sep 9, 2020
Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and
Completed
- Liver Cirrhoses
- +2 more
- Vitamin B12 and Folic Acid
-
Assiut, EgyptMohamed Shaban Redwan Helal
Oct 14, 2020
COVID-19 Trial in Mansoura (Sofosbuvir 400 MG plus Daclatasvir 200mg)
Unknown status
- COVID-19
- Sofosbuvir 400 MG plus Daclatasvir 200mg
-
Mansoura, Dakahlyia, EgyptMansoura Faculty of Medicine
Feb 22, 2021
Hepatitis C, Chronic Trial in Chennai (Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin)
Completed
- Hepatitis C, Chronic
- Sofosbuvir
- +2 more
-
Chennai, Tamil Nadu, IndiaYR Gaitonde Centre for AIDS Research and Education
Mar 22, 2021
HCV Infection Trial in Christchurch (SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol)
Chronic Hepatitis C Virus Infection Trial (Sofosbuvir + Simeprevir + Ribavirin)
Completed
- Chronic Hepatitis C Virus Infection
- Sofosbuvir + Simeprevir + Ribavirin
- (no location specified)
May 9, 2020
Chronic Hepatitis C Virus Infection Trial ((SOF and DCV), (SOF, DCV, and RBV))
Completed
- Chronic Hepatitis C Virus Infection
- (SOF and DCV)
- (SOF, DCV, and RBV)
- (no location specified)
May 13, 2020